(Q46483696)

22 December 2017

title

Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progression (English)

1 reference

22 December 2017

1 reference

1 reference

Afrodite Athanasopoulou

1

1 reference

22 December 2017

Panagiotis Aroukatos

2

1 reference

22 December 2017

Dimitrios Nakas

3

1 reference

22 December 2017

Maria Repanti

4

1 reference

22 December 2017

Helen Papadaki

5

1 reference

22 December 2017

Vasiliki Bravou

6

1 reference

22 December 2017

publication date

24 August 2011

1 reference

22 December 2017

published in

Urologic Oncology

1 reference

22 December 2017

volume

31

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

836-842

1 reference

22 December 2017

The actin cytoskeleton in cancer cell motility

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

ERM proteins and merlin: integrators at the cell cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Merlin and ERM proteins: unappreciated roles in cancer development?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Androgen induction of prostate cancer cell invasion is mediated by ezrin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

7 January 2021

Paxillin comes of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

From the membrane to the nucleus and back again: bifunctional focal adhesion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

7 January 2021

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Proepithelin Promotes Migration and Invasion of 5637 Bladder Cancer Cells through the Activation of ERK1/2 and the Formation of a Paxillin/FAK/ERK Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Protein expression patterns of ezrin are predictors of progression in T1G3 bladder tumours treated with nonmaintenance bacillus Calmette-Guérin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Accumulation of nuclear p53 and tumor progression in bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

p53 expression in patients with advanced urothelial cancer of the urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Activity and distribution of paxillin, focal adhesion kinase, and cadherin indicate cooperative roles during zebrafish morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Integrin-linked kinase cytoplasmic and nuclear expression in laryngeal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Primary hepatic malignant fibrous histiocytoma: clinicopathologic characteristics and prognostic value of ezrin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

ZO1 in corneal epithelium: association to the zonula occludens and adherens junctions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Intrinsic polarity of mammalian neuroepithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

Paxillin LD motifs may define a new family of protein recognition domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.003

10.1016/J.UROLONC.2011.07.003

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017